Literature DB >> 6157088

Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis.

A B Noronha, D P Richman, B G Arnason.   

Abstract

To examine the immune response in the central nervous system in patients with multiple sclerosis (MS), we characterized the cell-cycle phase of lymphocytes from cerebrospinal fluid. Cells were stained with acridine orange, and both RNA and DNA content were determined by flow cytometry. Although most cells were in the quiescent phase of the cycle, a significant increase was seen in the percentage of cells in the first stage of the proliferative cycle (G1 phase) when 21 samples of cerebrospinal fluid from 17 patients with MS were compared with samples from 21 controls (P < 0.001). Stimulated cells in the first stage of the cycle were seen in all categories of MS: active, progressive, or stable. In addition, increased numbers of cells in the second stage of the cycle (S phase) were seen in six specimens from patients with MS, five of whom had actie disease, but no increases were seen in controls (P < 0.02). These data indicate that stimulated lymphocytes were present in the cerebrospinal fluid durng all phases of MS and that stimulation becomes more intense during an acute exacerbation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157088     DOI: 10.1056/NEJM198009253031301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  12 in total

Review 1.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

Review 2.  Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

Authors:  U Traugott
Journal:  Springer Semin Immunopathol       Date:  1985

3.  HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis.

Authors:  S Fredrikson; A Karlsson-Parra; T Olsson; H Link
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

4.  Growth of antigen specific, HLA restricted T lymphocyte clones from cerebrospinal fluid.

Authors:  B Fleischer; U Bogdahn
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

5.  Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

Authors:  G Birnbaum; L Kotilinek; M Schwartz; M Sternad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Degradation of human myelin in vitro by leucocytes from patients with multiple sclerosis.

Authors:  S J Owen; C M Watson; A N Davison
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

7.  Long-term growth in vitro of human cerebrospinal fluid T lymphocytes.

Authors:  J B Burns; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1981-07       Impact factor: 8.317

8.  Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.

Authors:  S Fredrikson; P Eneroth; H Link
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  Differential abnormality in cell-cycle stage of peripheral B cells from patients with systemic lupus erythematosus.

Authors:  M Hara; A Kitani; M Harigai; T Hirose; K Norioka; W Hirose; K Suzuki; M Kawagoe; H Nakamura
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

10.  Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.

Authors:  K Selmaj; Z Nowak; H Tchórzewski
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.